Posted by Michael Wonder on 30 Jan 2022
PBS listing to benefit Australians with rare type of non-Hodgkin lymphoma
31 January 2022 - From 1 February, thousands of Australians with a relapsed and/or refractory mantle cell lymphoma, a form of non-Hodgkin lymphoma will have access to a new treatment through the Pharmaceutical Benefits Scheme.
Minister for Health and Aged Care, Greg Hunt, said more than 350 Australians with mantle cell lymphoma accessed a similar treatment through the PBS in 2020.
